Insto & Investor Roadshow to commence today starting in Brisbane, and followed by Sydney and Melbourne!
PBO Record Revevenues achieved beating prospectus forecasts by 15% for the second year running.
This is a fantastic small cap biotech Co that has gone largely un-noticed!
Panbio's Australian and North American branchs are exceeding forecasts. Roadshow should bring this to the attention of brockers, instos and smaller investors...
see> www.panbio.com.au
PBO Price at posting:
0.0¢ Sentiment: None Disclosure: Held
